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Insulin receptor substrate 2 (Irs2) plays complex roles in energy homeostasis. We generated mice lacking 
Irs2 in β cells and a population of hypothalamic neurons (RIPCreIrs2KO), in all neurons (NesCreIrs2KO), 
and in proopiomelanocortin neurons (POMCCreIrs2KO) to determine the role of Irs2 in the CNS and β cell. 
RIPCreIrs2KO mice displayed impaired glucose tolerance and reduced β cell mass. Overt diabetes did not 
ensue, because β cells escaping Cre-mediated recombination progressively populated islets. RIPCreIrs2KO 
and NesCreIrs2KO mice displayed hyperphagia, obesity, and increased body length, which suggests altered 
melanocortin action. POMCCreIrs2KO mice did not display this phenotype. RIPCreIrs2KO and NesCreIrs2KO 
mice retained leptin sensitivity, which suggests that CNS Irs2 pathways are not required for leptin action. 
NesCreIrs2KO and POMCCreIrs2KO mice did not display reduced β cell mass, but NesCreIrs2KO mice dis-
played mild abnormalities of glucose homeostasis. RIPCre neurons did not express POMC or neuropeptide Y. 
Insulin and a melanocortin agonist depolarized RIPCre neurons, whereas leptin was ineffective. Insulin 
hyperpolarized and leptin depolarized POMC neurons. Our findings demonstrate a critical role for IRS2 in 
β cell and hypothalamic function and provide insights into the role of RIPCre neurons, a distinct hypotha-
lamic neuronal population, in growth and energy homeostasis.
Introduction
Insulin regulates peripheral energy homeostasis by acting on mul-
tiple tissues to control carbohydrate, lipid, and protein metabolism 
(1). Gene targeting in mice has shown that β cell deletion of the 
insulin receptor causes reduced first-phase insulin release, reduced 
β cell insulin content, and progressive deterioration in glucose tol-
erance (2). Early studies of the effects of insulin in the CNS dem-
onstrated a role for intracerebroventricularly administered insulin 
in the control of food intake and body weight (3). Mouse brain 
insulin receptor deletion causes mild hyperphagia and adiposity 
in female mice, diet-sensitive obesity, and defects in reproductive 
function (4). Results from studies in which insulinomimetics and 
insulin receptor antisense were centrally administered also sup-
port a role for CNS insulin signaling in energy homeostasis regula-
tion (5, 6). Insulin signaling mechanisms therefore regulate β cell 
and CNS function, but it is unclear which postreceptor compo-
nents mediate which physiological effects and, in the case of the 
CNS, which neuronal populations are involved. It is also unclear 
how insulin signaling components interact with other molecules 
involved in energy homeostasis, such as leptin.
Insulin receptor substrate (Irs) proteins lie downstream of the 
activated insulin and type 1 insulin-like growth factor receptor (7). 
Gene targeting studies have revealed distinct physiological roles 
for the 4 major Irs proteins (7). Mice lacking Irs1 display profound 
growth retardation and insulin resistance but, due to β cell com-
pensation, do not develop diabetes (8, 9). Irs3- and Irs4-null mice 
have minimal metabolic, endocrine, and growth phenotypes (7). 
In contrast, mice lacking Irs2 develop diabetes due to insulin resis-
tance and pancreatic β cell dysfunction (10). These studies have 
suggested that Irs2 is the major mediator of the metabolic effects 
of insulin and have identified a novel role for Irs2 signaling in the 
maintenance of β cell mass. Irs2 signaling also plays complex roles 
in neuroendocrine function. Female Irs2-null mice are infertile, 
hyperphagic, and develop obesity (11). Irs2-null mice are reported 
to be leptin resistant (12), which suggests that Irs2 acts as a point 
of convergence for leptin and insulin signaling.
It has recently been reported that mice lacking Irs2 in both pancre-
atic β cells and a poorly defined hypothalamic neuronal population 
(generated using a rat insulin 2 promoter Cre [RIPCre] recombinase 
transgene) display reduced islet mass, impaired glucose tolerance, and 
hypothalamic dysfunction (13, 14). Unlike mice with global deletion 
of Irs2, these mice did not develop progressive diabetes. One study 
(13) reported that they displayed a hypothalamic phenotype sug-
gesting melanocortin dysfunction, proposed that RIPCre neurons 
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are proopiomelanocortin (POMC) neurons, and noted β cell recov-
ery with time through an undetermined mechanism. Another study 
(14) demonstrated reduced islet mass, obesity, and leptin resistance 
but did not report other features of hypothalamic dysfunction or 
long-term analysis of islet function. Consequently, these studies 
have raised a number of critical but unanswered questions (15). In 
particular it is unclear (a) why there is a relative recovery of the β cell 
phenotype; (b) what role the CNS plays in the β cell phenotype and 
the impairment of glucose homeostasis; (c) what is the role of Irs2 
in leptin action; and (d) what are the identity and characteristics of 
the hypothalamic neuronal population involved (15).
To address these questions, we generated mice lacking Irs2 
in specific cell types: RIPCreIrs2KO mice, lacking Irs2 in β cells 
and a poorly characterized population of hypothalamic neu-
rons; NesCreIrs2KO mice, lacking Irs2 in all neurons but not the 
endocrine pancreas; and POMCCreIrs2KO mice, lacking Irs2 in 
POMCCre-expressing cells.
Results
Generation of mice with a floxed allele of Irs2. We generated mice 
with a floxed allele of Irs2 (Irs2lox mice) to permit its deletion 
in different cell types and tissues (Figure 1, A–E). Irs2lox mice, 
when bred to homozygosity, were phenotypically indistinguish-
able from wild-type animals and displayed normal Irs2 expres-
sion (data not shown).
Using 3 Cre recombinase transgenic lines, we generated 
RIPCreIrs2KO, NesCreIrs2KO, and POMCCreIrs2KO mice. We 
also intercrossed RIPCre and POMCCre mice with ZEG (16) and 
Rosa26lacZ (17) indicator mice on both wild-type and Irs2lox/lox 
backgrounds. This allowed identification of cell types in which 
recombination occurred and permitted Irs2 deletion and GFP or 
lacZ expression in the same cell types. RIPCreZEG mice expressed 
GFP in pancreatic islets, hypothalamic structures such as the 
arcuate, lateral, and ventromedial hypothalamus (VMH), and a 
discrete population of forebrain neurons (Figure 1, F–H, and data 
not shown). In POMCCreZEG mice, GFP expression was found in a 
discrete population of arcuate nucleus neurons (Figure 1I). Com-
bined in situ hybridization (ISH) and immunocytochemistry (ICC) 
studies demonstrated colocalization of GFP and POMC (Figure 1J) 
in more than 90% of cells examined, which indicated that most 
POMC neurons also expressed functional Cre recombinase. No GFP 
expression was found in pancreatic β cells (data not shown). NesCre 
mice delete in neurons but not pancreatic endocrine cells (18) and 
have been used to manipulate insulin signaling in the CNS (4). 
Figure 1
Generation of Irs2flox mice and characteristics of RIPCre and POMCCre mice. (A) Schema of targeting construct design, simplified restriction map 
of the Irs2 locus, the locus after homologous recombination and the deletion of neomycin cassette (Neo), and Southern blotting and PCR genotyping 
strategies used to identify these events. External probe A was used to identify homologous recombination (HR), probe B to detect the selection 
cassette, and probe C to detect the coding region of Irs2. HSV-tk, herpes simplex virus thymidine kinase. (B) Southern blot analysis with probe A 
demonstrating homologous recombination after targeting. (C and D) Southern blots using probe B after Cre-mediated recombination demonstrating 
deletion (Del) of the neomycin cassette and using probe C to demonstrate retention of Irs2 coding region confirming type 2 recombination. (E) PCR 
analysis with primers P1 and P2 of HR clone that has lost the neomycin cassette but retained the loxP site downstream of the Irs2 coding region. 
(F–H) We examined Cre expression in RIPCre mice by analyzing GFP expression in pancreatic sections costained with insulin and hypothalamic 
sections from RIPCreZEG mice. (I) We examined Cre expression in POMCCre mice by analyzing hypothalamic sections from POMCCreZEG 
mice. (J) Combined ISH for POMC and ICC for GFP was performed in POMCCreZEG mice to confirm Cre expression in POMC neurons. (K) 
Immunohistochemistry for IRS2 (red) was performed in hypothalamic sections from POMCCreZEG mice. Scale bars: 50 μm (H, I, and K) and 10 μm (J). 
3V, third ventricle; ME, median eminence.
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Irs2 expression was found in pancreatic islets and in the arcuate, the 
VMH, and the paraventricular nucleus (Figure 1K and Figure 2B 
and data not shown).
To confirm deletion of Irs2 in the RIPCreIrs2KO, NesCreIrs2KO, 
and POMCCreIrs2KO mice, we analyzed recombination of the 
Irs2flox allele by PCR in islet and hypothalamic DNA. In 4-week- 
old mice, the recombined allele was detected in both tissues 
in RIPCreIrs2KO mice (Figure 2A) but only in the hypothal-
ami of NesCreIrs2KO and POMCCreIrs2KO mice (Figure 2A). 
Immunoprecipitation and Western blotting confirmed the lack of 
Irs2 expression in isolated islets from RIPCreIrs2KO and in either 
whole brain or hypothalamic lysates from NesCreIrs2KO mice 
(Figure 2, B and C). ICC analysis of RIPCreZEG mice demonstrat-
ed Irs2 colocalization with GFP in some but not all hypothalamic 
arcuate neurons (Figure 2D, left panel). In RIPCreIrs2KOZEG mice, 
there was no colocalization of Irs2 and GFP, which confirmed Irs2 
deletion in RIPCre neurons (Figure 2D, right). Irs2 expression 
remained in other hypothalamic neurons. Analysis of Irs2 expres-
sion in POMCCreZEG mice demonstrated colocalization of Irs2 
with GFP in some POMC neurons (Figure 2E). Irs2 deletion was 
confirmed in POMCCreIrs2KOlacZ mice (we were unable to breed 
POMCCreIrs2KOZEG mice), but Irs2 expression remained in other 
hypothalamic arcuate neurons (Figure 2F). Normal Irs2 expression 
was detected in muscle, liver, adipose, and other tissues in mice of 
all 3 lines (data not shown).
Glucose homeostasis in RIPCreIrs2KO, NesCreIrs2KO, and 
POMCCreIrs2KO mice. In 4-week-old male RIPCreIrs2KO, 
NesCreIrs2KO, and POMCCreIrs2KO mice, fasting blood glucose lev-
els were indistinguishable from those of control animals (data not 
shown). At 12 weeks of age, when male Irs2-null mice are diabetic, 
RIPCreIrs2KO mice had higher fasting blood glucose levels than 
control mice, and glucose tolerance tests revealed defective glucose 
disposal (Figure 3, A and B). However, the elevation in fasting blood 
glucose levels was modest, and thus RIPCreIrs2KO mice did not dis-
play the overt diabetes and catabolic state that Irs2-null mice devel-
op. Fasting glucose levels were also elevated in NesCreIrs2KO mice, 
and glucose tolerance was mildly impaired (Figure 3, A and C). 
RIPCreIrs2KO and NesCreIrs2KO mice at 6 months of age and older 
did not develop markedly elevated fasting blood glucose levels but 
remained glucose intolerant (Figure 3D and data not shown). In 
contrast, fasting glucose levels and glucose tolerance were equiva-
lent to those of controls in POMCCreIrs2KO mice at 12 weeks and 
older (Figure 3A and data not shown).
At 12 weeks, RIPCreIrs2KO and NesCreIrs2KO mice, but not 
POMCCreIrs2KO mice, displayed fasting hyperinsulinemia com-
pared with control animals, which suggests development of insu-
lin resistance (Figure 3E). At 6 months, both RIPCreIrs2KO and 
NesCreIrs2KO mice remained hyperinsulinemic (data not shown). At 
4 weeks, when there was a 50% reduction in β cell mass in Irs2-null 
mice (10), no decrease in β cell mass was seen in RIPCreIrs2KO 
compared with control animals (data not shown). However, by 12 
weeks, RIPCreIrs2KO mice had a 40% reduction in β cell mass com-
pared with control mice (Figure 3F, left), consistent with the dete-
rioration in glucose homeostasis at this age. In contrast, 12-week-
old NesCreIrs2KO mice exhibited an increased β cell mass, evidence 
of a compensatory response to insulin resistance (Figure 3F, left). 
POMCCreIrs2KO did not display altered β cell mass compared with 
age-matched controls (data not shown).
To investigate the preservation of glucose homeostasis com-
pared with Irs2-null mice, we examined β cell mass in 9-month-
old RIPCreIrs2KO mice. RIPCreIrs2KO mice had a reduced islet area 
compared with control animals (Figure 3F, right), but the area had 
increased from that seen in 12-week-old RIPCreIrs2KO mice, which 
suggests partial recovery in β cell mass (Figure 3F, right).
Hypothalamic function in RIPCreIrs2KO, NesCreIrs2KO, and 
POMCCreIrs2KO mice. RIPCreIrs2KO and NesCreIrs2KO mice dis-
played increased body weight compared with control mice starting 
around 4–5 weeks of age. By 12 weeks of age, they were 20% heavier 
than control animals (Figure 4A). RIPCreIrs2KO and NesCreIrs2KO 
mice were significantly longer than control mice (Supplemental 
Figure 1; supplemental material available online with this article; 
doi:10.1172/JCI200524445DS1). MRI scanning performed at 16 
Figure 2
Analysis of deletion of Irs2 in islets and hypothalami from RIPCreIrs2KO, POMCCreIrs2KO, and NesCreIrs2KO mice. (A) We performed PCR analy-
sis to detect recombination of the Irs2 locus in DNA from islets and hypothalami (hypo) of control and knockout mice. The presence of a 1.3-kb PCR 
product indicates recombination and deletion of the Irs2 gene. (B and C) Western blot analysis of Irs2 in islets from control and RIPCreIrs2KO mice 
(B) and whole brain and hypothalamic lysates from control and NesCreIrs2KO mice (C). (D) Immunofluorescence analysis for Irs2 expression in the 
hypothalami of RIPCreZEG and RIPCreIrs2KOZEG mice. Colocalization of GFP (green) and Irs2 (red) is seen in RIPCreZEG mice (indicated by white 
arrows) and no colocalization in RIPCreIrs2KOZEG mice. RIPCreGFP, GFP expression in RIPCre cells. (E) Colocalization of POMCCre expression 
and Irs2 in POMCCreZEG mice. (F) Colocalization of POMCCre expression and Irs2 in POMCCrelacZ mice and no colocalization of GFP and Irs2 
in POMCCreIrs2KOlacZ mice. Confocal images of representative arcuate nucleus fields are shown in D–F. Scale bars: 10 μm.
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weeks showed increased fat mass that was more significant in 
NesCreIrs2KO mice (Figure 4B). At 12 weeks, 24-hour food con-
sumption was greater in both RIPCreIrs2KO and NesCreIrs2KO mice 
than in control animals (Figure 4C). In contrast, analysis of rest-
ing metabolic rate, core temperature, and activity revealed no dif-
ferences between RIPCreIrs2KO or NesCreIrs2KO mice and control 
animals (Supplemental Table 1). Furthermore POMCCreIrs2KO 
mice did not display increased body weight (Figure 4A), were of 
the same length as controls (Supplemental Figure 1), and did not 
eat more than control mice (Figure 4C).
At 12 weeks of age when RIPCreIrs2KO and NesCreIrs2KO mice 
displayed marked obesity, leptin levels were significantly elevated 
in these mice but not in POMCCreIrs2KO mice (Figure 4D). We 
administered leptin (5 mg/kg) peripherally for 3 days to accli-
matized 6-week-old mice. This treatment inhibited cumulative 
3-day food intake in control animals by 20% compared with 
vehicle-treated animals (Figure 4, E and F). RIPCreIrs2KO and 
NesCreIrs2KO mice, despite being hyperphagic, also responded to 
leptin treatment with a 20% decrease in cumulative food intake 
(Figure 4, E and F). The reduction in food intake was accompa-
nied in control, RIPCreIrs2KO, and NesCreIrs2KO mice by a signifi-
cant reduction in body weight (Figure 4G). To further investigate 
the temporal development of the feeding phenotype, we measured 
leptin levels and food intake in 5-week-old male RIPCreIrs2KO 
mice. At this age, RIPCreIrs2KO mice were hyperphagic but did not 
display hyperleptinemia (Figure 4H). Findings for NesCreIrs2KO 
mice were similar (data not shown).
Characterization of β cell recovery in RIPCreIrs2KO mice. Our studies 
and others (13, 15, 19) raise the question of the mechanism for the 
relative recovery of the β cell mass in RIPCreIrs2KO mice with age. 
Analysis of 4-week-old RIPCreIrs2KOZEG mice demonstrated that a 
vast majority of insulin-positive cells coexpressed GFP, which sug-
gests that recombination was occurring in most β cells (Figure 5, 
A and B). However, we detected small numbers of insulin-express-
ing cells that were GFP negative (Figure 5B), which indicates lack of 
recombination and that the RIPCre promoter was not active in all 
β cells. It would be predicted that Irs2 would not be deleted in these 
cells and therefore they are involved in the preservation or recovery 
of β cell mass. Indeed, analysis of 9-month-old RIPCreIrs2KOZEG 
mice demonstrated that in many islets, a significant proportion 
of the insulin-positive β cells no longer expressed GFP (Figure 5, 
C and D). Comparison of the numbers of GFP-positive β cells in 
9-month-old mice demonstrated that GFP expression loss 
occurred significantly more often in RIPCreIrs2KOZEG than con-
trol mice (percentage of GFP-negative β cells: RIPCreIrs2KOZEG, 
50.9% ± 1.2% vs. RIPCreZEG, 10.1% ± 1.1%; P < 0.001; 2,062 β cells 
sampled in 54 islets from 4 RIPCreIrs2KOZEG mice and 2,987 β 
cells sampled in 45 islets from 3 RIPCreZEG mice).
To further characterize the mechanism of β cell recovery, we 
used a duct-specific lectin (Dolichos biflorus agglutinin [DBA]) to 
identify duct epithelial cells (20). GFP or insulin expression was 
not detected in DBA-positive duct structures in RIPCreIrs2KOZEG 
mice at 9 months of age (Figure 5, E–G). Likewise, in 9-month-
old RIPCreIrs2KOZEG mice, in 296 islets sampled from 4 mice, no 
Figure 3
Glucose homeostasis in RIPCreIrs2KO, NesCreIrs2KO, and POMCCreIrs2KO mice. (A) Fasting blood glucose levels of 12-week-old male 
mice of the indicated genotypes were measured after a 16-hour overnight fast. (B). Glucose tolerance tests were performed on 12-week-
old male RIPCreIrs2KO (filled squares) and control mice (open squares). (C) Glucose tolerance tests were performed on 12-week-old male 
NesCreIrs2KO (filled squares) and control mice (open squares). (D) Fasting blood glucose levels of 6-month-old male mice of the indicated 
genotypes were measured after a 16-hour overnight fast. (E) Fasting blood insulin levels of 12-week-old male mice of the indicated genotypes 
were measured after a 16-hour overnight fast. Data in A–E represent the mean ± SEM for 8–10 animals of each genotype. (F) We calculated 
the percentage of the total pancreatic area occupied by β cells in 12-week-old male mice of the indicated genotypes using insulin-stained 
pancreatic sections. The right side shows data for 9-month-old RIPCreIrs2KO and control mice. Four pancreata were analyzed per genotype at 
each time point, and for each pancreas, 4 sections were analyzed. The data presented are mean ± SEM for 4 mice of each genotype. *P < 0.05, 
**P < 0.01, and ***P < 0.001. Cont, control.
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DBA-positive cells were found within islets (Figure 5, E–G). These 
findings suggest that duct cells that have differentiated to insu-
lin-producing cells within ducts or duct cells that migrate to islet 
structures before converting to β cells do not make a significant 
contribution to the β cell repopulation. These findings do not 
exclude the possibility that ductal precursor cells that express nei-
ther duct markers nor insulin are involved in this process.
Characterization of RIPCre neurons and comparison with POMC neurons. 
Our studies demonstrate that RIPCre neurons play a role in energy 
homeostasis and growth and that deletion of Irs2 in these cells gener-
ates a phenotype with similarities to that of melanocortin pathway 
mutants. However, our genetic evidence suggests that deletion of Irs2 
in POMC neurons does not account for the hypothalamic pheno-
type seen in RIPCreIrs2KO or NesCreIrs2KO mice. RT-PCR analysis of 
expression of hypothalamic feeding peptides in RIPCreIrs2KO and 
NesCreIrs2KO mice demonstrated reduced POMC expression (POMC 
mRNA: 42% reduction in NesCreIrs2KO mice normalized to control 
mice, P < 0.05, n = 5; 48% reduction in RIPCreIrs2KO mice normalized 
to control mice, P < 0.05, n = 8) but normal neuropeptide Y (NPY) and 
agouti-related protein (AgRP) expression (data not shown), which 
suggests an effect on melanocortin circuits. No alteration in hypotha-
lamic POMC, AgRP, and NPY expression was seen in POMCCreIrs2KO 
mice. Therefore, to characterize the relationship between RIPCre neu-
rons and melanocortin pathways, we performed ISH/ICC analysis 
and electrophysiological studies of RIPCre and POMCCre neurons. 
POMC- and GFP-expressing neurons in the hypothalamus were clear-
ly identified by ISH and ICC, respectively, in the same slices (Figure 6, 
A and B), and no GFP-positive neurons colocalized with POMC 
mRNA. POMC and RIPCre neurons, however, are closely associ-
ated with each other. Similarly, no coexpression of GFP was dem-
onstrated in NPY neurons, but close apposition of these neuronal 
populations was observed (Figure 6, C and D). Combined ICC for α 
melanocyte-stimulating hormone (αMSH) and GFP demonstrated 
no coexpression, but many GFP neurons were in close proximity to 
αMSH-positive fibers, which suggests that they may be targets for 
POMC neurons (Figure 6E).
Whole-cell current-clamp recordings were made from GFP-posi-
tive hypothalamic arcuate neurons from RIPCreZEG mice. Under 
control recording conditions, RIPCre neurons spontaneously fired 
action potentials and had a mean resting potential of –50 ± 1 mV 
Figure 4
Hypothalamic function in RIPCreIrs2KO, NesCreIrs2KO, and POMCCreIrs2KO mice. (A) Body weight was measured in 12-week-old male mice 
of the indicated genotypes. (B) Total body fat was determined by MRI in 16-week-old male mice of the indicated genotypes. (C) Cumulative 
24-hour food intake was measured in 12-week-old male mice of the indicated genotypes. (D) Fasting blood leptin levels of 12-week-old male mice 
of the indicated genotypes were measured after a 16-hour overnight fast. (E–G) Cumulative food intake, percent reduction in food intake com-
pared with baseline, and reduction in bodyweight were measured over a 3-day period of treatment with leptin (5 mg/kg) or vehicle in 6–8-week-
old male mice of the indicated genotypes. (H) Food intake and fasting leptin levels were determined in 5-week-old male mice of the indicated 
genotypes. Data in A–H data represent the mean ± SEM for 8–10 animals of each genotype. *P < 0.05, **P < 0.01, and ***P < 0.001.
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and input resistance of 1,862 ± 197 MΩ (n = 62). Bath applica-
tion of the αMSH analog melanotan II (MTII) (a nonselective 
melanocortin 3/4 receptor agonist) at 100 nM caused long-lasting 
depolarization in the majority of cells tested (from –53 ± 3 mV to 
–48 ± 2 mV; P < 0.01; n = 9/13), associated with increased spike 
firing (Figure 6, F and G).
To demonstrate the MTII excitatory effect more clearly, we 
applied a small hyperpolarizing current to individual neurons, 
such that action potential frequency was markedly reduced. 
Under these conditions, MTII (100 nM) caused depolarization and 
increased firing frequency (Figure 6H). Furthermore, the applica-
tion of MTII (100 nM) to RIPCre neurons, following incubation 
of the slice with tetrodotoxin (TTX; 500 nM) to block spike firing 
and prevent synaptic transmission, caused significant depolariza-
tion (n = 4), which indicates a direct action (Figure 6I). To further 
characterize RIPCre neurons and differentiate them from POMC 
(and NPY) neurons, we determined the actions of insulin and 
leptin on the electrical properties of RIPCre and POMC neurons. 
Leptin has been demonstrated to depolarize POMC neurons (21), 
and our current results support this finding. Pressure ejection of 
leptin (50 nM) for 60 seconds directly above the recorded neuron 
caused an increase in spike frequency and a small depolarization 
(from –47 ± 2 mV to –44 ± 3 mV; P < 0.04) of a minority population 
of POMC neurons (n = 5/13) (Figure 7, A–C). In contrast, leptin 
(50 nM) did not affect action potential frequency or resting mem-
brane potential (–46 ± 3 mV vs. –47 ± 3 mV; n = 10; Figure 7, D and E) 
in RIPCre neurons. Pressure ejection of insulin (10 nM) for 60 sec-
onds produced a significant increase in action potential frequency, 
concomitant with cell depolarization (from –49 ± 4 to –40 ± 4 mV; 
P < 0.01) in the majority of recordings (n = 6/9) from RIP-
Cre neurons (Figure 7, F–H). In contrast, pressure injec-
tion of insulin (10 nM) onto POMC neurons resulted 
in hyperpolarization (from –48 ± 1 mV to –55 ± 2 mV; 
P < 0.001) and reduced action potential frequency in most 
(n = 9/11) neurons (Figure 7, I and J). 
The effect of insulin, MTII, and 
leptin on neuronal activity was 
extremely slow to reverse and 
was, in many cases, irrevers-
ible over the time course of the 
experiments. These experiments 
suggest that RIPCre neurons 
are a population distinct from 
either POMC or NPY neurons 
but lie within a melanocortin- 
and insulin-regulated neuronal 
mechanism.
Discussion
Through global gene deletion, 
we and others have previously 
implicated Irs2 in the regulation 
of β cell function and peripheral 
glucose metabolism and the 
central regulation of energy 
homeostasis (10, 11, 19, 22). 
These studies have suggested 
but not proved that Irs2 medi-
ates both β cell growth and 
leptin and insulin action in the 
CNS. To elucidate the contribution of Irs2 to this complex phe-
notype in specific tissues, we generated mice with a conditional 
allele of Irs2 to permit deletion in a number of cell types. We ini-
tially used RIPCre transgenic mice to generate RIPCreIrs2KO mice 
lacking Irs2 in β cells and a population of hypothalamic neurons, 
and indeed it has recently been reported that RIPCreIrs2KO mice 
display phenotypes due to this mixed pattern of deletion (13, 14). 
These mice developed reduced β cell mass, obesity, somatic 
overgrowth, hyperinsulinemia, and hyperleptinemia but did 
not progress to an overt diabetic phenotype because of an unex-
plained recovery in β cell mass. However, because of the inabil-
ity to dissociate β cell and hypothalamic phenotypes, a number 
of questions regarding the role of Irs2 remain unanswered (15). 
To directly address such issues that we encountered with our 
own RIPCreIrs2KO mice, we also generated NesCreIrs2KO mice, 
lacking Irs2 in all neurons but not the endocrine pancreas, and 
POMCCreIrs2KO mice, lacking Irs2 in hypothalamic POMC neu-
rons, which have been implicated in mediating leptin’s effects on 
energy homeostasis (23).
Consistent with recent reports (13, 14), 12-week-old 
RIPCreIrs2KO mice had reduced β cell mass and displayed mildly 
elevated fasting blood glucose levels, impaired glucose tolerance, 
and hyperinsulinemia. They developed a marked hypothalamic 
phenotype resembling that of mice with defects in melanocortin 
action. In contrast, NesCreIrs2KO mice, which have normal β cell 
Irs2 expression, had increased β cell mass in response to insulin 
resistance and displayed the obesity and overgrowth syndrome. 
These findings demonstrate that β cell mass reduction is due 
to Irs2 deletion solely in β cells and not in the CNS. However, 
NesCreIrs2KO did develop elevated fasting blood glucose levels 
and hyperinsulinemia, which suggests that neuronal Irs2 path-
ways are required for normal glucose homeostasis but that the 
increase in β cell mass seen in NesCreIrs2KO mice could compen-
sate for insulin resistance.
Figure 5
Analysis of recombination and duct-marker expression in islets from RIPCreIrs2KOZEG mice. (A–D) 
Immunofluorescence staining for insulin (red) in islets from 4-week-old (A and B) and 9-month-old (C and D) 
RIPCreIrs2KOZEG mice stained for DNA (DAPI, blue). White arrows indicate β cells that do not express 
GFP and have not undergone recombination. Many cells in the 9-month-old islet do not express GFP. (E–G) 
Labeling of ducts with DBA in islets from 9-month-old RIPCreIrs2KOZEG mice stained blue for either DNA 
(E and F) or insulin (G). No duct marker is expressed in GFP-negative β cells. Scale bars: 100 μm.
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In contrast to Lin et al. (13), we found that in 9-month-old 
RIPCreIrs2KO mice, there was a persistent reduction in β cell 
mass compared with that of control mice, although the mass was 
increased compared with that of 3-month-old RIPCreIrs2KO mice. 
At later ages, therefore, RIPCreIrs2KO mice had glucose intolerance 
but did not display marked fasting hyperglycemia and never devel-
oped the marked progressive diabetic phenotype of the global Irs2-
null mouse. Anatomical studies of recombination using a GFP indi-
cator mouse in either a wild-type or Irs2flox background revealed 
that as early as 4 weeks, small numbers of β cells did not harbor the 
recombination event. By 9 months of age, significant numbers of 
β cells in RIPCreIrs2KO mice not expressing GFP had repopulated 
the islets, but many GFP-positive cells undergoing recombination 
were still present, which explains the persistent reduction in β cell 
mass. Our studies demonstrate that the reduction in recombina-
tion occurs predominantly in RIPCreIrs2KOZEG as opposed to 
RIPCreZEG islets, which suggests that Irs2 signaling itself is required 
for expression of the RIPCre transgene. Indeed, insulin gene expres-
sion appears to require an intact insulin signaling pathway in the β 
cell (2, 24, 25). With Irs2 largely absent within β cells, under condi-
tions of insulin resistance there may be potential selection for pre-
existing β cells not expressing the RIPCre transgene and therefore 
not undergoing deletion of Irs2 to expand and repopulate the islet. 
In 9-month-old mice, we did not detect GFP expression and Cre-
mediated recombination in pancreatic ducts, and so potentially the 
GFP-negative β cells could have arisen from duct cells. However, we 
could not detect expression of a duct cell marker within islets of 
9-month-old RIPCreIrs2KO mice nor could we find insulin expres-
sion in ducts. The absence of deletion in ducts also suggests that 
the β cell phenotype in RIPCreIrs2KO mice results from loss of 
Figure 6
Characterization of RIPCre neurons by ICC, ISH, and electrophysiological analysis. (A and B) Dual ISH for POMC and ICC for GFP was performed 
on hypothalamic sections from RIPCreZEG mice. Representative low- (A) and high-power (B) views are shown. (C and D) Dual ISH for NPY and 
ICC for GFP was performed on hypothalamic sections from RIPCreZEG mice. Representative low- (C) and high-power (D) views are shown. ARC, 
arcuate nucleus. (E) Fluorescence ICC for POMC was performed on hypothalamic sections from RIPCreZEG mice. Neurons expressing POMC are 
red and those expressing GFP are green. Arrows indicate noncolocalized neurons and GFP neurons that are abutted by POMC fibers. A representa-
tive confocal image is shown. Scale bars: 50 μm (A and C) and 10 μm (B, D, and E). (F–I) Current-clamp recordings were made from RIPCreZEG 
neurons in the absence and presence of the mixed melanocortin 3/4 receptor agonist MTII, as indicated above the traces. (F) Representative 
recording demonstrating MTII depolarization, resulting in a small increase in spike frequency (G). This depolarization is more clearly represented 
in neurons that have sub-spike thresholds, achieved by application of a constant hyperpolarizing current (H). MTII also depolarizes neurons in the 
presence of TTX (I), indicative of a direct action. The action potentials in panel H have been truncated to show clearly the depolarizing effect of MTII. 
Note that the MTII depolarization was irreversible over the time course of the recordings in cells represented in H and I.
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Irs2 in mature insulin-producing cells rather than any precursor 
or stem cell population. Taken together, these findings provide 
anatomical evidence that a small number of preexisting β cells that 
escape Irs2 deletion at an early stage in RIPCreIrs2KO mice repopu-
late the islets. Our studies cannot categorically exclude the possibil-
ity that duct-derived precursors expressing neither insulin nor duct 
markers contribute to the repopulation process. However, recent 
lineage tracing studies (20) suggest that proliferation of mature β 
cells is the major mechanism for β cell expansion in adult mice. Our 
findings suggest that persistent Irs2 expression in mature β cells is 
required for the compensatory response to insulin resistance.
The preservation of β cell mass in NesCreIrs2KO mice dissoci-
ates hypothalamic dysfunction from reduced β cell mass. It has 
been suggested that nestin expression is a characteristic of pan-
creatic islet stem cells (26, 27), but recently lineage tracing stud-
ies, utilizing the same NesCre mouse used in our studies, dem-
onstrated that pancreatic exocrine, ductal, and endothelial cells 
but not islet endocrine cells express nestin (18, 28). The finding 
of increased islet mass in NesCreIrs2KO mice further supports the 
concept that nestin-positive cells do not contribute to the endo-
crine pancreas, as deletion of Irs2 in these cells would have been 
anticipated to reduce β cell mass.
The hypothalamic phenotypes seen in RIPCreIrs2KO and 
NesCreIrs2KO mice suggested defects in melanocortin function, 
and in RIPCreIrs2KO and NesCreIrs2KO mice, we detected reduced 
hypothalamic POMC expression. Deletion of the leptin receptor in 
POMC neurons generates mice that have some phenotypic features 
in common with RIPCreIrs2KO mice, including obesity (23). It has 
been suggested that RIPCre neurons are POMC neurons and that 
Irs2 signaling events are required for central leptin action (14, 29). 
Our results, however, do not confirm these findings and provide 
evidence to define the role and sites of Irs2 pathways in the CNS. 
We demonstrate that deletion of Irs2 in POMC neurons did not 
recapitulate the hypothalamic phenotype and that RIPCre neurons 
do not express POMC or NPY. Furthermore, RIPCreIRS2KO and 
NesCreIRSKO mice were sensitive to peripherally administered leptin 
at 6 weeks of age. Five-week-old RIPCreIRS2KO and NesCreIRSKO 
mice are hyperphagic but not hyperleptinemic, which suggests that 
elevated leptin levels seen at later ages result from greater adiposity 
due to increased energy intake rather than primary central leptin 
resistance. This is consistent with the observation that central 
leptin administration to Irs2-null mice causes reduction in fat mass 
(12). Young nonobese hyperphagic melanocortin 4 receptor–null mice, 
which resemble RIPCreIRS2KO and NesCreIRSKO mice, are sensitive 
Figure 7
Electrophysiological characteristics of RIPCre and POMC neurons in response to insulin and leptin. (A) Representative recordings from individual 
arcuate neurons are shown for POMCCreZEG (A–C, I, and J) and RIPCreZEG (D–H). Leptin (50 nM) and insulin (10 nM) were pressure-ejected 
(2–5 psi) for 60 seconds (as denoted by arrows). (A) Leptin depolarizes the POMCCreZEG neuron, and this is associated with significant attenu-
ation of spike amplitude. The recording from the neuron shown in B was hyperpolarized to subthreshold potentials by injection of constant current 
(2–5 pA) through the recording electrode. Application of leptin depolarized and increased the firing rate of the neuron. (C) Diary plot of spike 
frequency for the neuron shown in B. In contrast, leptin had no effect on membrane potential (D) and spike frequency (E) in RIPCreZEG neurons. 
Insulin caused depolarization of the RIPCreZEG neuron (F) and increased spike frequency (G), with spike attenuation. As shown in H, the neuron 
was hyperpolarized to subthreshold potentials as above, and application of insulin clearly depolarizes this neuron with a large increase in spike 
frequency. In contrast, insulin caused hyperpolarization of POMCCreZEG neurons (I), which was accompanied by a reduction in firing rate (J).
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to the anorexigenic effects of leptin but develop leptin resistance 
as they become obese (30). In preliminary observations, mice lack-
ing Irs2 in AgRP neurons, generated using an AgRPCre transgenic 
mouse (31), also do not develop a marked hypothalamic phenotype 
(H. Al-Qassab et al., unpublished observations). Therefore, these 
studies implicate Irs2 signaling in neurons distinct from POMC 
and AgRP/NPY populations in the regulation of energy homeosta-
sis and growth and suggest that Irs2 is not an obligatory compo-
nent of CNS leptin signaling pathways.
Electrophysiological analysis showed that RIPCre neurons depo-
larized in response to insulin and MTII, which suggests that they 
could be mediating the effects of insulin in the CNS in a mela-
nocortin-sensitive neuronal pathway. Furthermore, we found no 
electrophysiological effect of leptin upon arcuate RIPCre neurons, 
which suggests that this is not a leptin-sensitive neuronal popula-
tion and therefore may explain why RIPCreIRS2KO mice are not 
leptin resistant. In contrast, leptin depolarized and insulin hyper-
polarized POMC neurons. These opposite effects upon neuronal 
activity perhaps explain the lack of phenotype in POMCCreIrs2KO 
mice and distinguish RIPCre neurons electrophysiologically from 
both POMC and NPY neurons (21, 32). It remains possible that 
the RIPCre neurons in other hypothalamic regions such as the 
VMH may be mediating the effects of leptin, and we have started 
to examine this possibility using additional mouse mutants. How-
ever, our observation of leptin sensitivity in the NesCreIrs2KO mice 
suggests that CNS Irs2 is not required for leptin action.
Our studies have demonstrated that CNS Irs2 pathways acting 
in a neuronal population distinct from POMC and NPY neurons 
regulate energy homeostasis and growth. Arcuate RIPCre neurons 
are targets for insulin and melanocortin but not leptin action, but 
it remains to be determined what neuropeptides and transmitters 
are expressed in this population. Irs2 in β cells is required for the 
maintenance of β cell mass, but β cells that escape Cre-mediated 
recombination are able to repopulate islets with time. Our obser-
vations clarify the role of Irs2 in β cell function and energy homeo-
stasis and suggest that modulation of Irs2 function may be of use 
in the treatment of diabetes and obesity.
Methods
Generation of floxed allele of Irs2 and genotyping strategies for Irs2lox and Cre and 
ZEG transgenic mice. The murine Irs2 gene was cloned from a 129Sv mouse 
genomic PAC library. We cloned 2.8 kb of 5′ homology from the Irs2 locus 
upstream of a floxed neomycin cassette using appropriate linkers. The Irs2 
coding region was subcloned with linkers, introducing a loxP site 3′ to the 
Irs2 coding region. A 3-kb fragment of 3′ region of the Irs2 locus was cloned 
downstream of this loxP site using linkers to generate the final construct 
(Figure 1A). 129Sv/EvTac1 ES cells were transfected with Pac1-linearized 
targeting construct by electroporation. Cells were subjected to selection 
with G418 and ganciclovir; surviving clones were expanded and genomic 
DNA extracted and subjected to analysis by PCR and Southern blotting to 
detect homologous recombination (Figure 1, B–D). Targeted clones were 
subsequently transfected with Cre recombinase plasmid to remove the 
neomycin cassette and screened by Southern blotting and PCR (Figure 1, 
C and D). ES cells were injected into blastocysts derived from C57BL/6J mice, 
which were implanted into pseudopregnant CD-1 foster mothers. Chimeric 
male mice were bred with C57BL/6J mice and germ-line transmission con-
firmed by PCR and Southern blot analysis. Irs2lox mice were intercrossed 
with C57BL/6J RIPCre and C57BL/6J NesCre mice obtained from the Jack-
son Laboratory (33, 34) to generate compound heterozygous mice. Double-
heterozygous mice were crossed with Irs2lox mice to obtain WT, Irs2lox/lox, Cre, 
and CreIrs2lox/lox mice. Mice lacking Irs2 in RIPCre-expressing cells were desig-
nated RIPCreIrs2KO and in nestin Cre–expressing cells NesCreIrs2KO. POMCCre 
mice were generated using a BAC transgenic approach (35). POMCCre 
mice were intercrossed with Irs2lox mice and bred as described above to obtain 
POMCCreIrs2KO mice. ZEG mice, which carry a Cre-activated GFP transgene 
(16), or Rosa26lacZ indicator mice (17) were intercrossed with the RIPCre and 
POMCCre mice and Irs2lox mice to obtain mice that express GFP or lacZ in 
RIPCre- or POMCCre-expressing cells as well as mice that also lack Irs2 and 
express the indicator gene. Mice were maintained on a 12-hour light/dark 
cycle with free access to water and standard mouse chow (4% fat, RM1; Special 
Diet Services) and housed in specific pathogen–free barrier facilities. Mice were 
handled and all in vivo studies performed with approval by the Home Office 
(London, United Kingdom). All knockout and transgenic mice were studied 
with appropriate littermate controls. Wild-type, Cre transgenic and Irs2lox/lox 
mice were phenotypically indistinguishable, and equal numbers of the mice of 
these genotypes were used as controls. Genotyping of the mice was performed 
by PCR amplification of tail DNA. For Irs2lox genotyping, we used primers 
that flank the 3′ loxP site (Figure 1E): loxP forward, 5′-ACTTGAAGGAAGC-
CACAGTCG-3′ and loxP reverse, 5′-AGTCCACTTTCCTGACAAGC-3′. Cre 
recombinase, Rosa26lacZ, and ZEG genotyping was performed as previously 
described (16, 17). For detection of Cre-mediated excision of Irs2, genomic 
DNA was isolated from pancreatic islets, hypothalami, and other tissues by 
heating in 50 mM NaOH at 100°C for 10 minutes. Primers located 1.1 kb 
upstream of the 5′ loxP site (5′-GGGAACCTGACAAGTGAATG-3′) and 0.2 kb 
downstream of the 3′ loxP site (loxP 5′-AGTCCACTTTCCTGACAAGC-3′) 
amplified a 1.3-kb product if recombination had occurred.
Immunoprecipitation and Western blotting. Tissues were removed and 
homogenized in lysis buffer, solubilized for 30 minutes on ice, and clari-
fied by centrifugation. Supernatants were immunoprecipitated for 2 hours 
with an anti-Irs2 antibody as described (10). Immune complexes were col-
lected with 100 μl of 50% slurry of protein A-sepharose, washed with lysis 
buffer, resolved on 7.5% SDS-PAGE, and transferred to nitrocellulose. The 
blots were probed with polyclonal antibody against Irs2 and enhanced che-
miluminescence (Amersham Biosciences) detection.
Metabolic studies. Body weights were determined using a Sartorius BP610 
balance. Nose to anus length was measured either postmortem or in anes-
thetized mice, with the observer blinded to genotype. Blood samples were 
collected from mice via tail vein bleeds or from cardiac puncture performed 
on terminally anesthetized mice. Blood glucose was measured using a Glu-
cometer Elite (Bayer Corp.). We determined plasma insulin levels using an 
ultrasensitive rat insulin ELISA (Crystalchem Inc.) using a mouse standard 
and leptin levels using a mouse leptin ELISA (Crystalchem Inc.). Glucose 
tolerance tests were performed on mice after a 16-hour overnight fast. Ani-
mals were injected intraperitoneally with D-glucose (1.5 g/kg) and blood 
glucose levels determined at the time points indicated in Figure 3, B and C.
Food intake and leptin and treatment studies. Mice were singly housed and 
allowed to acclimatize for a week prior to study. Food intake and body weight 
were measured for 3 consecutive days at the ages indicated in the Figure 4 
legend. As necessary, we acclimatized mice by subjecting them to overnight 
fasts and sham injections prior to the study protocol. For peripheral leptin 
treatment, mice were treated with either 5 mg/kg recombinant mouse leptin 
(R&D Systems) or vehicle injected i.p. 1 hour before lights out for 3 consecu-
tive days. Food and body weights were recorded before injection, during the 
treatment period, and for a 3-day wash-out period following the study.
ICC and ISH. Brains were harvested following transcardiac perfusion 
with RNAse-free PBS and 4% paraformaldehyde, postfixed in 4% 
paraformaldehyde, and transferred to RNAse-free 30% sucrose prior to 
freezing. Thirty-micrometer floating sections were cut using a sliding 
microtome. Twenty-micrometer cryostat sections were thaw-mounted 
on polylysine-coated microscope slides. Floating sections were washed 
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in potassium PBS (KPBS), pH 7.4, blocked with 2% serum in KPBS/0.4% 
Triton X-100 (KPBS-T) for 1 hour at room temperature, and then incu-
bated with primary antibodies in KPBS-T for 48 hours at 4°C. Slices were 
incubated with appropriate secondary antibodies for 1 hour in KPBS-T 
before being washed in KPBS. For chromogenic detection, slices were 
incubated for 60 minutes in avidin-DH/biotinylated HRP (ABC Elite; 
Vector Laboratories) in KPBS-T and washed in KPBS, then in 150 mM 
sodium acetate, and nickel-enhanced detection was performed with a 3,3′-
diaminobenzidine substrate kit for peroxidase (Vector Laboratories). For 
some anti-αMSH staining experiments, mice were treated with intracere-
broventricular colchicine (2 μl of 20 mg/ml solution in 0.9% saline infused 
over 10 minutes into the lateral ventricle) 24 hours prior to perfusion 
fixation and biotinylated tyramide amplification and fluorescent detec-
tion with streptavidin-conjugated Alexa Fluor 594 (Invitrogen Corp.) were 
used. Slices were mounted on polylysine-coated microscope slides and 
coverslipped with buffered glycerol. Primary antibodies used were rab-
bit anti-Irs2 antibody (United Biomedical Inc.), sheep anti-NPY (Chemi-
con International), sheep anti-αMSH (Chemicon International), mouse 
monoclonal anti-GFP (Chemicon International), and mouse monoclonal 
anti-lacZ (Promega). For combined ISH and ICC, ISH was performed first 
under RNAse-free conditions. In brief, sections on slides were fixed in 
formaldehyde solution for 20 minutes on ice, washed twice in PBS for 5 
minutes, and acetylated at room temperature for 10 minutes in 0.1 M tri-
ethanolamine (pH 8.0) with acetic acid anhydride. After washing, sections 
were dehydrated and air dried for 30 minutes. Hybridization buffer con-
taining 2 ng/μl digoxigenin-labeled (DIG-labeled) probe was applied and 
sections covered with glass coverslips and hybridized overnight at 60°C. 
Sections were placed in 4× SSC to remove coverslips, RNase A treated for 
30 minutes at 37°C, and washed in 2× SSC at 6°C for 10 minutes, 1× 
SSC at 6°C for 10 minutes, 0.5× SSC at 60°C twice for 10 minutes, and 
0.1× SSC at 60°C for 30 minutes. Sections were cooled to room tempera-
ture in 0.1× SSC, and we used alkaline phosphatase–conjugated anti-DIG 
antibody to detect bound DIG-labeled probe (Roche Diagnostics Ltd.) as 
described above. We generated ISH riboprobes using mouse sequences 
(POMC, GenBank accession number NM_008895; NPY, GenBank acces-
sion number NM_023456). Imaging was performed with an Olympus 
BX51 microscope with either a Hamamatsu 95 black-and-white camera 
or a Jenoptik ProgRes C14 color camera combined with SimplePCI cap-
ture and deconvolution software (version 5.2.1, Compix Inc.). Confocal 
microscopy was performed on a Bio-Rad MRC1000 microscope. Colocal-
ization of either POMC or NPY with GFP was scored in 4 arcuate sections 
from each of 4 RIPCreZEG mice by 2 independent observers.
Pancreatic ICC and measurement of islet mass and number. Pancreata were 
removed, cleared of fat and lymph nodes, fixed in Bouins solution, embed-
ded in paraffin, and cut into 5-μm sections. For GFP detection, pancreata 
were harvested from paraformaldehyde-perfused mice as described above. 
For insulin staining, sections were incubated with blocking solution con-
taining PBS buffer with 5% normal chicken serum and 2% BSA for 30 min-
utes, and mouse anti-insulin antibody (clone K36aC10; Sigma-Aldrich) 
was then applied for 2 hours at room temperature or overnight at 4°C. The 
sections were then incubated with chicken anti-mouse IgG–AlexaFluor 488 
conjugate (Invitrogen Corp.) for 2 hours at room temperature. Transmit-
ted light and fluorescent images were captured as described above. For 
quantification of β cell area, we analyzed 5 pancreata per genotype at each 
time point using 4 sections at least 150 μm apart from each other. For each 
section, the total area occupied by insulin-positive cells was scored using 
SimplePCI software. Results are expressed as the percentage of the total 
pancreatic area. Pancreatic ducts were labeled with biotinylated DBA lectin 
(Vector Laboratories), detection performed with fluorescently labeled 
streptavidin 610 (Invitrogen Corp.), and DAPI used to identify nuclei.
Islet isolation. Mice were sacrificed, the common bile duct cannulated, 
and its duodenal end occluded by clamping. Two milliliters of collagenase 
V solution (1 mg/ml in HBSS) was injected into the duct to distend the 
pancreas. The pancreas was excised, incubated at 37°C for 15 minutes, 
and mechanically disrupted in 10 ml of HBSS. Cellular components were 
collected by centrifugation (220 g for 1 minute) and resuspended in 10 ml 
of HBSS. Islets were handpicked under a microscope and washed once in 
HBSS. Islets were centrifuged at 15,600 g for 5 minutes and stored at –20°C 
until DNA or protein extraction.
mRNA quantification by RT-PCR analysis. Hypothalami were removed from 
fasted mice, homogenized in Trizol reagent (Invitrogen Corp.), and 1 μg 
RNA was reverse transcribed using Taqman reagents (Applera Ltd.). Quan-
titative PCR was carried out with first-strand cDNA with primers for hypo-
thalamic feeding peptides (23), using hypoxanthine ribosyl transferase as 
an internal control on an ABI Prism 7900HT sequence detection system, 
with SYBR green reagents (Applied Biosystems Inc.), and data analyzed 
according to the 2–ΔΔCT method (36).
Electrophysiology. Male RIPCreZEG and POMCCreZEG mice (8–16 weeks 
old) were killed by cervical dislocation. Brains were rapidly transferred to 
a ice-cold slicing solution containing 2.5 mM KCl, 1.25 mM NaH2PO4, 
28 mM NaHCO3, 0.5 mM CaCl2, 7 mM MgCl2, 7 mM D-glucose, 1 mM 
ascorbate, 3 mM pyruvate, and 235 mM sucrose and equilibrated with 
95% O2/5% CO2 to give a pH of 7.4, and 350-μm coronal brain slices were 
prepared using a Vibratome Series 1000. Arcuate nucleus slices were kept 
at room temperature in a normal external solution containing 125 mM 
NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 25 mM NaHCO3, 2 mM CaCl2, 
1 mM MgCl2, 10 mM D-glucose, 15 mM D-mannitol, 1 mM ascorbate, 
and 3 mM pyruvate equilibrated with 95% O2/5% CO2, pH 7.4. For whole-
cell recordings, slices were continuously perfused with normal external 
solution (in the absence of ascorbate and pyruvate and with CaCl2 and 
MgCl2 concentrations adjusted to 0.5 and 2.5 mM, respectively) at a rate of 
5–10 ml/min. Neurons were identified using epifluorescence and differ-
ential interference contrast optics using an upright Zeiss Axioskop 2 FS 
plus microscope. Borosilicate patch pipettes (5–8 MΩ) were filled with an 
internal solution containing 130 mM potassium gluconate, 10 mM KCl, 
0.5 mM EGTA, 10 mM HEPES, 1 mM NaCl, 0.28 mM CaCl2, 3 mM MgCl2, 
3 mM NaATP, 0.3 mM tris-GTP, 14 mM phosphocreatine (pH 7.2). Data were 
recorded and stored on digital audio tape, which enabled off-line analysis. 
We examined changes in input resistance by monitoring membrane poten-
tial responses to negative, rectangular current pulses (5–20 pA, 200 ms, 
0.05 Hz) injected via the recording electrode. Application of drugs was 
made via the bath perfusion system or locally by pressure ejection from a 
broken pipette (approximately 5-μm tip) positioned approximately 50 μm 
above the recorded neuron at the concentrations indicated.
MRI and magnetic resonance spectroscopy. Mice were scanned using a 4.7T 
Varian system under isoflurane anesthesia. Whole-body images (between 
50 and 60 slices; 2 mm thick) were obtained for each mouse using a spin-
echo sequence (TR4500/TE20). Semiautomatic image segmentation soft-
ware (sliceOmatic version 4.2; Tomovision) was used to separate and quan-
tify tissue volumes (37). For adipose tissue, the volume was multiplied by a 
correction factor of 0.9 in order to account for hydration (38).
Statistical analysis. All statistics were performed using GraphPad Prism 4 
software and paired and unpaired Student’s t tests and 2-way ANOVA, with 
Bonferroni post-hoc tests performed as appropriate.
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